Please wait...

Efforts towards developing the ecosystem for human vaccine manufacturing in Kenya

Kenya Biovax Institute CEO Dr. Michael Lusiola held talks with a delegation from United States Pharmacopeia (USP) to explore areas of collaboration in local human vaccines production.
Zlatka Kostova the Vaccines Director at Promoting Quality of Medicines Plus (PQM plus) led the delegation from USP for a meeting with Kenya Biovax Institute team.
Kenya Biovax Institute and United states Pharmacopeia (USP) discussed areas of partnership including; knowledge transfer, workforce development, human vaccine regulatory approvals among others.
Kenya Biovax Institute CEO Dr. Michael Lusiola held talks with a delegation from United States Pharmacopeia (USP) to explore areas of collaboration in local human vaccines production.
admin
Fri, 10/14/2022 - 10:36
Published